Literature DB >> 3500208

Evidence for an association between CD8 molecules and the T cell receptor complex on cytotoxic T cells.

S Takada1, E G Engleman.   

Abstract

The T cell differentiation molecule CD8 is thought to play an important role in class I major histocompatibility complex-restricted T cell activities but the precise function of this molecule is unknown. To explore this question, we have studied several CD3+, CD8+ class I alloantigen-specific cytotoxic T lymphocyte (CTL) lines and clones. The ability of these CTL to proliferate as well as to lyse specific targets was inhibited by either anti-CD3 or anti-CD8 monoclonal antibodies. Exposure of CTL to relevant but not irrelevant target cells induced the rapid (less than 1 hr) disappearance of approximately 20 to 30% of CD3 and CD8 molecules from the cell surface. The modulation of these molecules became maximal at 6 to 12 hr and recovered thereafter in parallel. Treatment of CTL with anti-CD8 prevented alloantigen-induced modulation of CD3, and treatment with anti-CD3 blocked modulation of CD8. Incubation of CTL with the combination of anti-CD3 and goat anti-mouse Ig also resulted in modulation of CD8. In contrast, the expression of other CTL surface antigens, such as CD2 (Leu-5, T11) and HLA-DR, was not reduced by any of these manipulations. These results suggest that CD8 molecules are associated with the CD3/antigen receptor complex on the surface of CTL, and may play a direct role in antigen-induced modulation and cross-linking of the T cell receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500208

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Molecular cloning, reconstruction and expression of the gene encoding the alpha-chain of the bovine CD8--definition of three peptide regions conserved across species.

Authors:  P Lalor; C Bucci; M Fornaro; M C Rattazzi; H Nakauchi; L A Herzenberg; S Alberti
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

2.  Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse.

Authors:  Pia P Yachi; Jeanette Ampudia; Nicholas R J Gascoigne; Tomasz Zal
Journal:  Nat Immunol       Date:  2005-06-26       Impact factor: 25.606

3.  Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity.

Authors:  Naoto Hirano; Marcus O Butler; Zhinan Xia; Sascha Ansén; Michael S von Bergwelt-Baildon; Donna Neuberg; Gordon J Freeman; Lee M Nadler
Journal:  Blood       Date:  2005-10-20       Impact factor: 22.113

4.  Isolation and properties of a Lyt-2.1-negative mutant of a Lyt-2.1/Lyt-2.2 CTL line.

Authors:  Z T Chu; J T Kung; C Thomas; K A Wall; P D Gottlieb
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  The analysis of lymphocyte surface receptors recognized by wheat germ agglutinin for negative regulation of immune responses in cancer patients.

Authors:  Y Yamaguchi; T Toge; N Baba; H Kuninobu; Y Kegoya; T Takayama; T Hattori
Journal:  Jpn J Surg       Date:  1990-01

6.  A secreted form of the human lymphocyte cell surface molecule CD8 arises from alternative splicing.

Authors:  P Giblin; J A Ledbetter; P Kavathas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 7.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

8.  Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis.

Authors:  B J Nickoloff; T Wrone-Smith
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

9.  Phosphorylation and down-regulation of CD4 and CD8 in human CTLs and mouse L cells.

Authors:  J P DiSanto; J S Klein; N Flomenberg
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

10.  The role of lymphocyte surface binding sites for wheat germ agglutinin in the negative regulation of cancer patients.

Authors:  T Toge; Y Yamaguchi; A Sawamura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.